"Dr Reddy"

Latest news and video coverage curated from trusted media outlets

You Might Like

Covid-19 vaccine: Dr Reddy's Lab to seek approval for Sputnik Light as universal booster dose In September 2020, Dr. Reddy's partnered with Russian Direct Investment Fund to conduct clinical trials of Sputnik V and distribute vaccine in India. DNA - Published on May 19, 2022
Shrikant Chouhan: BUY BHEL and Dr Reddy’s TopNews - Published on April 6, 2022
Sudarshan Sukhani: BUY Bajaj Finserv, Dr Reddy’s, Havells India; SELL Tata Steel TopNews - Published on March 30, 2022
Indian cos stay put in Russia but pharma exports could be hit Pharmaceutical major Dr Reddy's Laboratories said on Wednesday it was focused on business continuity in and around Russia, as Indian drug exporters brace for temporary disruptions to sales due to the.. IndiaTimes - Published on March 9, 2022
Pharma major Dr. Reddy's plans 'business continuity' in Russia Pharmaceutical major Dr. Reddy's Laboratories Ltd said on Wednesday it was focused on employee safety and business continuity in and around Russia, despite many Western companies pulling out from.. IndiaTimes - Published on March 9, 2022
Mankind to buy 2 brands from DRL Mankind Pharma has said it has entered into an agreement with Dr Reddy’s (DRL) to acquire two brands, ‘Combihale’ and ‘Daffy’. While Combihale is used for the treatment of asthma and chronic.. IndiaTimes - Published on February 18, 2022
Varun Dubey: BUY IRCTC, Dr Reddy’s, Tata Motors DVR and Schaeffler India TopNews - Published on February 17, 2022
Novartis signs exclusive sales and distribution agreement with Dr Reddy's Labs newKerala.com - Published on February 12, 2022
Sputnik Light is second vaccine to be made available in India by Dr. Reddy’s Indian Express - Published on February 7, 2022
Submitted proposal to DCGI to test Sputnik Light as Covid booster dose: Dr Reddy's IndiaTimes - Published on February 6, 2022
Dr Reddy's Laboratories to acquire German medical firm Nimbus Health newKerala.com - Published on February 4, 2022
Dr Reddy's Laboratories posts Rs 707 crore profit in Q3 newKerala.com - Published on January 28, 2022
Trying to bring Sputnik M vaccine for adolescents to India: Dr Reddy's IndiaTimes - Published on January 28, 2022	Dr Reddy's Molflu for Covid treatment at Rs 35 per capsule newKerala.com - Published on January 5, 2022
Mitessh Thakkar: BUY Voltas, GNFC, Dr Reddy’s; SELL Glenmark TopNews - Published on January 5, 2022	Dr Reddy's to launch Molflu at Rs 35 per capsule for Covid treatment Dr Reddy's Laboratories on Tuesday said it will launch Molflu (Molnupiravir) at Rs 35 per capsule to treat Covid-19 in the country.Molflu will be priced at Rs 35 per capsule, a spokesperson of the.. IndiaTimes - Published on January 4, 2022
Dr Reddy's to launch generic Covid-19 Merck drug at about 50 cents a pill IndiaTimes - Published on January 4, 2022	Covid antiviral pill launched at 1,399 for full 5-day course Over a dozen companies, including Hetero, Sun Pharma, Natco and Dr Reddy’s are in the process of rolling out the oral therapy developed by Merck and and its partner, Ridgeback Biotherapeutics, at.. IndiaTimes - Published on January 3, 2022
Dr Reddy's to soon launch Molnupirvair capsules newKerala.com - Published on December 29, 2021	Dr Reddy's Laboratories to introduce Molnupiravir to treat Covid-19 shortly IndiaTimes - Published on December 28, 2021
Sensex ends 296 points higher; Nifty tops 17,050 Tech Mahindra was the top gainer in the Sensex pack, rising over 3 per cent, followed by Dr Reddy's, PowerGrid, Kotak Bank, Sun Pharma, ICICI Bank and M&M. Zee News - Published on December 27, 2021	Mitessh Thakkar: BUY Dr Reddy’s, HCL Tech, Colgate-Palmolive; SELL SBI TopNews - Published on December 22, 2021
Dr. Reddy's open to making Pfizer Covid pill after Merck deal IndiaTimes - Published on November 15, 2021	Dr Reddy's to seek nod for Sputnik Light Even as Dr Reddy's Laboratories is gearing up to submit Phase-3 clinical trials data of the single-dose Russian vaccine Sputnik Light to the Drugs Controller General of India (DCGI) in November, it is.. IndiaTimes - Published on October 30, 2021
PM Narendra Modi meets India`s Covid vaccine manufacturers Representatives from seven vaccine makers - Serum Institute of India, Bharat Biotech, Dr Reddy's Laboratories, Zydus Cadila, Biological E, Gennova Biopharma and Panacea Biotech - participated in the.. Zee News - Published on October 23, 2021	Gulf Islamic Investment to Open Office in Bengaluru Eyes Strengthening Indo-UAE Investment Ties Gulf Islamic Investment (GII), a leading UAE-based Shari'ah-compliant financial services firm with over $2 billion of assets under management, today announced its foray into Karnataka, India to.. NewsVoir - Published on October 18, 2021
Dr Reddy's brushes way into Guinness World Records with largest toothbrush sculpture of tooth IndiaTimes - Published on September 28, 2021	CareerLabs partners with Dr. Reddy's for their new Chemical Engineering Certification programme newKerala.com - Published on September 21, 2021Also reported by •NewsVoir
Dr Reddy’s to sell its rights of anti-cancer agent to Citius Pharma IndiaTimes - Published on September 4, 2021	Sensex, Nifty start on choppy note on profit booking, weak global cues PowerGrid was the top loser in the Sensex pack, shedding over 1 per cent, followed by Bajaj Auto, Maruti, Dr Reddy`s, Asian Paints and Titan. Mid-Day - Published on August 16, 2021
Dr Reddy`s Lab partners with B Medical systems to provide vaccine storage solution Under this collaboration, B Medical Systems will install several hundreds of vaccine freezers across the country for the national roll-out of Sputnik V vaccines. Zee News - Published on August 9, 2021	Mandaviya discusses vax production with Dr Reddy's Lab Chairman newKerala.com - Published on August 5, 2021
Panacea Biotec to manufacture up to 25 million doses of Sputnik V vaccine The company has entered into a "licensing and manufacturing agreement with Human Vaccine Limited Liability Company, a subsidiary of Russian Direct Investment Fund, Russia, Generium Joint Stock.. IndiaTimes - Published on August 5, 2021	Sensex crosses 54,000 mark for first time, HDFC jumps 4.6% The other prominent gainers were Cipla, Dr Reddy's, Reliance Industries, JSW Steel and Tata Steel. DNA - Published on August 4, 2021
'Made in India' Sputnik V COVID-19 vaccine doses to be available from September-October: Dr Reddy's Laboratories newKerala.com - Published on August 2, 2021	Made in India Sputnik V to be available in Sep-Oct: Dr Reddy's newKerala.com - Published on July 28, 2021
Sensex drops over 250 pts in early trade; Nifty slips below 15,700 Nestle India was the top loser in the Sensex pack, shedding over 1 per cent, followed by Dr Reddy’s, HDFC twins, Axis Bank, Kotak Bank, TCS, Reliance Industries and Infosys Mid-Day - Published on July 28, 2021Also reported by •Zee News	Covid-19 surge in Russia hits supplies of Sputnik V in India On the vaccine crunch that has been hampering a wider rollout of the Russian vaccine in India, Dr Reddy’s Labs’ CEO branded markets M V Ramana said that the spike in Covid-19 cases in Russia had.. IndiaTimes - Published on July 28, 2021
Dr Reddy’s tanks 10% on news of US legal action IndiaTimes - Published on July 28, 2021	Sensex tumbles for 2nd day as Asian sell-off deepens on China crackdown; Dr Reddy's tanks 10% post earnings The 30-share BSE Sensex skidded 273.51 points or 0.52 per cent to finish at 52,578.76, while the broader NSE Nifty fell 78 points or 0.49 per cent to 15,746.45. Zee News - Published on July 27, 2021
Dr Reddy's profit drops 36% to Rs 380.4 crore in June quarter Dr Reddy's Laboratories on Tuesday reported 36 per cent decline in consolidated net profit at Rs 380.4 crore for the quarter ended June 30, 2021, on account of higher expenses. IndiaTimes - Published on July 27, 2021	SuperBeings Raise Seed Round Led by Endiya Partners Bengaluru-based integrated leadership success platform for growing organizations, *SuperBeings* on Thursday raised its seed round led by *Endiya Partners*. The round also saw participation from.. NewsVoir - Published on July 22, 2021
Sputnik V commercial launch in coming weeks: Dr Reddy's With the commercial rollout of Russian Covid-19 vaccine Sputnik V yet to take off three months after it received the Drugs Controller General of India (DCGI) emergency use authorisation (EUA), Dr.. IndiaTimes - Published on July 14, 2021	Soft launch of Sputnik V not put on hold: Dr Reddy's newKerala.com - Published on July 13, 2021
Dr Reddy's Laboratories assures to strengthen commercial roll-out of Sputnik V in coming weeks newKerala.com - Published on July 13, 2021	Sputnik V soft launch not put on hold, Dr Reddy`s Laboratories issues statement Dr Reddy's Laboratories said that the nationwide soft launch of Sputnik V has reached over 50 cities and towns across the country. Zee News - Published on July 13, 2021
'Will strengthen commercial roll-out of Sputnik V vaccine in India in coming weeks', assures Dr Reddy's Laboratories "We will strengthen the commercial roll-out of Sputnik V in the coming weeks. Neither the ongoing soft commercial launch nor work towards its ramp-up in India has been put on hold," said Dr Reddy's.. IndiaTimes - Published on July 12, 2021